Biological studies on individual bleomycins.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000627:therapeutic use* / Q000633:toxicity; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001808:Blood Vessels; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D003300:Copper / Q000378:metabolism; D005260:Female; D007106:Immune Sera; D007279:Injections, Subcutaneous; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008168:Lung / Q000187:drug effects; D051379:Mice; D010537:Peritoneum / Q000187:drug effects; D010539:Permeability; D011817:Rabbits; D051381:Rats; D012517:Sarcoma, Yoshida / Q000188:drug therapy*; D012867:Skin / Q000187:drug effects; D012878:Skin Neoplasms / Q000188:drug therapy*; D013154:Spleen / Q000187:drug effects; D014556:Urine; D014599:Uterus / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D007106:Immune Sera; D003300:Copper